Abstract:Yong Chen, 1 Yan-Juan Chen, 1 Jian-Feng Luo, 2 Mang He, 1 Si-Jin Zhao, 3 Shi-Dan Tian, 1 Yong-Qiao Zhang, 3 Xiao-Long Chen, 3 Chuan-Jie Yang, 3 Yu-Zhuo Luo, 3 Kutty Selva Nandakumar, 4 Mei Tian 1 1 Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China; 2 Department of Biostatistics, School of Public Health, Fudan University, Shanghai, People's Republic of China; 3 The First School of Clinical Medicine, Zunyi Medical University, Zunyi, People's Republic of China; 4 Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden Correspondence: Mei Tian, Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi City, Guizhou Province, 563000, People's Republic of China, Email Kutty Selva Nandakumar, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, 17177, Sweden, Email Purpose: The quality of life (QoL) of elderly patients with rheumatoid arthritis (RA) in Zunyi China based on health parameters has not been previously analyzed. This study compares the 36-Item Short Form Health Survey (SF-36) scores and prevailing health complications between < 60y and ≥ 60y patients with RA. Data from 1166 patients with RA who visited the rheumatology department of Zunyi Medical University Hospital were followed up and retrospectively analyzed. Patients and Methods: Data from 1166 patients with RA who visited the rheumatology department of Zunyi Medical University Hospital (2021.1– 2022.8) were followed up and retrospectively analyzed. Results: Twenty cases passed away at 61.55 ± 8.11y, which was 6.75 years less than the local average age of death. Elderly patients with RA reported lower recovery levels, and their levels of inflammatory markers such as Immunoglobulin M-rheumatoid factor (IgM-RF), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels were significantly higher than those of younger patients during their past one-year observation period. The SF-36 results indicated that eight items of QoL in the elderly patients were all significantly inferior to < 60y patients, while the complications of interstitial lung disease (ILD), latent tuberculosis infection (LTBI) and, lung and herpes zoster infections were significantly higher. Conclusion: Elderly patients had a higher disease activity along with poor QoL, more health-related complications, and susceptibility to infections. Our study emphasizes the imperative need for optimization of RA treatment modalities in the elderly to alleviate their sufferings. Keywords: elderly rheumatoid arthritis, SF-36 scores, clinical characteristics, treatment outcomes The elderly rheumatoid arthritis (RA) population consists of both elderly-onset RA (EORA) that manifests after the age of 60 years and individuals diagnosed with RA early in life who aged naturally to become members of this group. 1 Much attention has been paid to the EORA cohort, which is believed to possess more remarkable features of acute onset and higher disease activity. 2 Irrespective of the subtypes, elderly RA is a diagnosis criteria that combines RA and aging. Although it may seem strange to many doctors, aging is now considered as a disease that could be diagnosed according to the World Health Organization's International Classification of Diseases (ICD-10/11). 3 The elderly RA population is expanding due to increased life expectancy and EORA incidence. The autoimmune reactions due to RA foster the process of aging, known as inflammaging; 4 on the other hand, during aging, organisms tend to develop a characteristic inflammatory state that expresses higher levels of pro-inflammatory markers, leading to the patients having more susceptibility to infections, age-related disease onset, and neoplasms. 5 Adding basic principles and characteristic features of geriatrics in their diagnosis may help rheumatologists evaluate the disease development in elderly RA for designing proper treatment strategies. Direct observation of the differences in patients' age is essential; however, only a small number of research studies were undertaken along these lines. 1 As robust treatment-to-target approaches must be balanced against adverse events due to increased comorbidities observed in the elderly RA population, while the clinical characteristics are not fully validated, the management of disease development in these patients can be challenging. There is also a limitation in the treatment approac -Abstract Truncated-

Age and quality of life in patients with rheumatoid arthritis treated with biologic agents

How Were the Elderly RA Patients Doing Over the Past Year?—A Post Hoc Analysis for Telephone Based Following Up to RA Patients in Zunyi China

Age-related Genes USP2 and ARG2 Are Involved in the Reduction of Immune Cell Infiltration in Elderly Patients with Rheumatoid Arthritis.

Influences of advanced age in rheumatoid arthritis: A multicentre ultrasonography cohort study

Relation between Functional Status and Quality of Life of the Elderly with Rheumatoid Arthritis

[Cross-Sectional Study on Quality of Life and Disease Activity of Rheumatoid Arthritis Patients].

Should we reconsider the definition of elderly-onset rheumatoid arthritis in an ageing society?

Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry

Quality of Life Assessment in Female Rheumatoid Arthritis Patients

The role of demographic and clinical variables in assessing the quality of life of outpatients with rheumatoid arthritis

The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis

Disability and Health-Related Quality of Life in Chinese Patients with Rheumatoid Arthritis: A Cross-Sectional Study.

Clinical Characteristics of Elderly and Younger Onset Rheumatoid Arthritis

Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post-hoc analysis of Japanese phase 3 clinical trials

Features and Outcomes of Elderly Rheumatoid Arthritis: Does the Age of Onset Matter? A Comparative Study From a Single Center in China

Quality of Life in Patients with Rheumatoid Arthritis – a Preliminary Study

Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients

Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study

Associations between clinical metrics of joint deformity, disease duration, disease activity, functional capacity, quality of life, pain, and fatigue in patients with rheumatoid arthritis

Unveiling the arthritis divide: Exploring treatment response and impact in late-onset vs. young-onset rheumatoid arthritis

P963 The comparative effectiveness and safety of different biologics in young (<60 years) versus elderly (≥60 years) patients with IBD: results from a real-world experience at a Belgian tertiary centre